Home » Stocks » Neuronetics

Neuronetics, Inc. (STIM)

Stock Price: $5.75 USD 0.14 (2.50%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed
After-hours: $5.74 -0.01 (-0.17%) Oct 26, 5:36 PM

Stock Price Chart

Key Info

Market Cap 108.46M
Revenue (ttm) 54.57M
Net Income (ttm) -34.80M
Shares Out 18.86M
EPS (ttm) -1.87
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $5.75
Previous Close $5.61
Change ($) 0.14
Change (%) 2.50%
Day's Open 5.79
Day's Range 5.29 - 5.93
Day's Volume 183,866
52-Week Range 1.25 - 9.10

More Stats

Market Cap 108.46M
Enterprise Value 91.38M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 18.86M
Float 11.61M
EPS (basic) -1.87
EPS (diluted) -1.87
FCF / Share -2.03
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 977,128
Short Ratio 2.70
Short % of Float 8.41%
Beta 2.56
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.99
PB Ratio 3.59
Revenue 54.57M
Operating Income -30.49M
Net Income -34.80M
Free Cash Flow -38.09M
Net Cash 17.08M
Net Cash / Share 0.91
Gross Margin 86.61%
Operating Margin -55.87%
Profit Margin -63.80%
FCF Margin -69.80%
ROA -19.40%
ROE -77.97%
ROIC -89.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 4
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(34.78% upside)
Current: $5.75
Target: 7.75
*Average 12-month price target from 4 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth18.72%30.53%18.13%-
Gross Profit47.2740.3330.8027.61
Operating Income-26.93-19.83-13.61-9.34
Net Income-29.04-24.10-16.06-11.23
Shares Outstanding18.388.950.190.15
Earnings Per Share-1.58-2.69-86.34-76.95
Operating Cash Flow-30.48-20.59-11.14-8.54
Capital Expenditures-0.81-1.01-0.59-0.32
Free Cash Flow-31.30-21.60-11.74-8.87
Cash & Equivalents76.5910529.1517.04
Total Debt34.3330.4029.5620.14
Net Cash / Debt42.2674.19-0.41-3.10
Book Value47.8571.04-193-177
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Neuronetics, Inc.
Country United States
Employees 114
CEO Keith J. Sullivan

Stock Information

Ticker Symbol STIM
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: STIM
IPO Date June 28, 2018


Neuronetics, a commercial stage medical technology company, designs, develops, and markets products for patients with psychiatric disorders in the United States, Japan, and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrist customers. Neuronetics, Inc. was founded in 2003 and is headquartered in Malvern, Pennsylvania.